Skip to main content

Synergus

  • Home
  • About
    • Our Publications
    • Employment Opportunities
    • Intern/Thesis Opportunities
    • Find Us
    • Privacy Policy
    • Contact Us
    • IGES group
  • RWE impact
    • Data that makes the difference
    • Real World Data / Statistical analysis
    • Evidence For Decisions
  • Market Access
    • Countries
    • Diagnostics
    • Digital Health
    • Medical Device
      • Market access strategy
      • Hands-on market access support
      • Reimbursement dossier / HTA dossier
      • Reimbursement/DRG analysis
    • Pharma
  • HEOR
    • Health Economics
      • Cost Effectiveness and Budget Impact Modelling
      • Economic Outcomes in Clinical Studies
    • Value Demonstration
  • Events/Webinars
  • News
  • Blog

  • Home
  • About
    • Our Publications
    • Employment Opportunities
    • Intern/Thesis Opportunities
    • Find Us
    • Privacy Policy
    • Contact Us
  • RWE impact
    • Data that makes the difference
    • Real World Data / Statistical analysis
    • Evidence For Decisions
  • Market Access
    • Countries
    • Diagnostics
    • Digital Health
    • Medical Device
      • Market access strategy
      • Reimbursement/DRG analysis
      • Reimbursement dossier / HTA dossier
      • Hands-on market access support
    • Pharma
  • HEOR
    • Health Economics
      • Cost Effectiveness and Budget Impact Modelling
      • Economic Outcomes in Clinical Studies
    • Value Demonstration
  • Events/Webinars
  • News
  • Blog

Blog

Unlocking Real-World Evidence utilising lab results – case study in Kidney disease in Denmark
02 Jun 2025

Tags:
RWD_DKDenmark
read more
Integration of Treatment council to The Danish Healthcare Quality Institute (DHQI) - Impacting Medtech and Diagnostics
23 May 2025

Tags:
RWD_DKHTA
read more
EU HTA for IVD's
22 Apr 2025

Tags:
EU HTAR IVD
read more
EU HTA for Medtech
14 Apr 2025

Tags:
EU HTAR Medtech
read more
Germany is introducing 20 % performance-based pricing on digital health
28 May 2024

Tags:
Real World EvidenceDHS Germany
read more
Real-World data provide essential insights about Myeloma
23 May 2024

Tags:
SwedenMyelomaReal World Evidence
read more
R-RCT from the Obesity registry resolve uncertainty about comparative effectiveness
28 Apr 2024

Tags:
SwedenR-RCTObesity
read more
Swedish drug registry – Data since 2005 and perfect linkage to other datasets
13 Apr 2024

Tags:
SwedenReal World Evidence
read more
Denmark Aims for "Digital First"
02 Jan 2024

Tags:
DenmarkDigital Health
read more
Class IIb and III – Clarify Eligibility for 137 (h) prior to submitting NUB in Germany!
17 Sep 2023

Tags:
GermanyCoverage with Evidence DevelopmentMedical Device
read more
  • Show More

Contact us

Tags

Breast cancer
Corona virus
DHS France
EMA
EQ-5D
EU HTAR
EU HTAR IVD
EU HTAR Medtech
Germany
HQ_RWD
Imaging
Myeloma
Obesity
Patient Registries
Pharma
RWD Scientific Impact
RWD_DK
Transferability of Outcomes
Coverage with Evidence Development
DHS Germany
Italy
Melanoma
Multiple Sclerosis
Quality of Life
R-RCT
Registries
SF-36
DHS Belgium
Funding
HQRWE_Fracture
Netherlands
Rheumatoid Arthritis
Throat Cancer
Co-payment
Empowered Patients
Lung Cancer
Norway
Stroke
Digital Heath Strategies
France
Innovation Funding
Mental Health
Data Science in Oncology
Finland
Heart Failure
Out-patient procedures
Artificial Intelligence
Denmark
Diabetes
Dementia
Sweden
Alzheimer
The Netherlands
Oncology
United Kingdom
Country specific
China
COVID-19
Value Based Healthcare
HTA
RefugeeMD
Medical Device
Disease Specific
Health Economics
Legislation
Market Access
IVD
Digital Health
Real World Data
Real World Evidence
  • Home
  • About
  • RWE impact
  • Market Access
  • HEOR
  • Events/Webinars
  • News
  • Blog